Adelaide S. Robb, MD


Children's National Medical Center


  • Advisory Board: Actavis; Eli Lilly and Company; Lundbeck Inc; National Institute of Child Health and Human Development; Patient-Centered Outcomes Research Institute; Pfizer Inc.
  • Consultant: Bristol-Myers Squibb; Eli Lilly and Company; Lundbeck Inc; National Institute of Child Health and Human Development; Otsuka America Pharmaceutical, Inc.; Patient-Centered Outcomes Research Institute
  • Grant Support: Bristol-Myers Squibb; Forest Laboratories, Inc.; GlaxoSmithKline; Janssen-Cilag Pty Limited; Lundbeck Inc; Merck & Co., Inc.; National Institute of Child Health and Human Development; National Institute of Neurological Disorders and Stroke; Pfizer Inc.; Sunovion Pharmaceuticals Inc.; SyneuRx
  • Honorarium for participation in another meeting: American Academy of Pediatrics; Bracket; Eli Lilly and Company; Patient-Centered Outcomes Research Institute
  • Honorarium for participation in this meeting: American Academy of Child & Adolescent Psychiatry
  • Research Support: SyneuRx
  • Serve on two DSMBs: Otsuka America Pharmaceutical, Inc.
  • Speakers Bureau: Lundbeck Inc; Pfizer Inc.; Takeda Pharmaceuticals U.S.A., Inc.
  • Stock or Equity: Eli Lilly and Company; GlaxoSmithKline; Johnson & Johnson Services, Inc.; Pfizer Inc.
  • Travel Support for participation in another meeting: Actavis; American Academy of Pediatrics; Bristol-Myers Squibb; Eli Lilly and Company; Forest Laboratories, Inc.; GlaxoSmithKline; Janssen-Cilag Pty Limited; Lundbeck Inc; Merck & Co., Inc.; Otsuka America Pharmaceutical, Inc.; Patient-Centered Outcomes Research Institute; Pfizer Inc.; Sunovion Pharmaceuticals Inc.; Takeda Pharmaceuticals U.S.A., Inc.
  • Travel Support to attend this meeting: American Academy of Child & Adolescent Psychiatry

Copyright © 2015 - American Academy of Child Adolescent Psychiatry. All Rights Reserved.